In this model, some key genetic alterations are progressively acquired during disease progression: p53 mutations and p53 LOH at early stages, KRAS mutations at the high-dysplasia stage and APC and GSK3β mutations at the carcinoma stage [163]. The gene discussed is TP53; the disease is carcinoma.